Nemluvio Side Effects

Generic name: nemolizumab

Medically reviewed by Drugs.com. Last updated on Oct 10, 2024.

Note: This document provides detailed information about Nemluvio.

Applies to nemolizumab: parenteral prefilled pen Side Effects associated with nemolizumab. Some dosage forms listed on this page may not apply specifically to the brand name Nemluvio.

Applies to nemolizumab: parenteral prefilled pen.

Side effects include:

Atopic dermatitis: Most common adverse reactions (≥1%) were headache (including migraine), arthralgia, urticaria, myalgia.

Prurigo nodularis: Most common adverse reactions (≥1%) were headache, dermatitis atopic, eczema, eczema nummular.

For healthcare professionals

Applies to nemolizumab: subcutaneous powder for injection.

Dermatologic adverse events

• Common (1% to 10%): Dermatitis atopic, eczema, eczema nummular^[Ref]

Hypersensitivity

• Frequency not reported: Hypersensitivity reactions^[Ref]

Nervous system

• Common (1% to 10%): Headache^[Ref]

See also:

Further information

Nemluvio side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer